Company intelligence / Profile preview
FUJIFILM Toyama Chemical
- Ownership
- Private
- Development stage
- Commercial
Overview
FUJIFILM Toyama Chemical has over 40 years of expertise in anti-infective drugs and sterile manufacturing. It operates Japan’s first commercial-scale GMP facility for liposome formulations. The company provides CDMO services spanning small molecules to advanced modalities like lipid nanoparticles and mRNA therapeutics. Its own R&D focuses on infectious disease and oncology with investigational programs in early clinical stages using novel DDS technologies
- Therapeutic areas
- OncologyInfectious Diseases
- Modalities
- Small moleculeLiposomeLipid nanoparticle delivery therapymRNA-based drugs
- Industry
- Pharma
Drug pipeline
9 assets8 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on FUJIFILM Toyama Chemical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FUJIFILM Toyama Chemical.